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Abstract. The association of EGF with its receptor in 
endosomeS isolated from rat liver homogenates was as- 
sessed biochemically by polyethylene glycol precipita- 
tion and morphologically by electron microscope ra- 
dioautography.  The proportion of receptor-bound 
ligand in endosomes at  15 min after the injection of 
doses of 0.1 and 1 #g EGF/100 g body weight was 
57 %.  This value increased to 77 % for the dose of 10 
/xg EGF injected. Quantitative electron microscope 
radioautography carried out on endosomes isolated at 
15 min after the injection of 10/~g  J25I-EGF demon- 
strated that most radiolabel was over the endosomal 
periphery thereby indicating that ligand-receptor com- 
plexes were in the bounding membrane but not in in- 
traluminal  vesicles of the content.  EGF receptor auto- 
phosphorylation activity during  internalization  was 
evaluated in plasmalemma and endosome fractions. 
This activity was markedly but transiently  reduced on 
the cell surface shortly after the administration  of 
saturating doses of EGE  The same activity, however, 
was augmented and prolonged in endosomes for up to 
30 min after EGF injection.  The transient desensitiza- 
tion of cell surface activity was not due to prior in 
vivo phosphorylation since receptor dephosphorylation 
in vitro failed to restore autophosphorylation activity. 
Transient desensitization of cell surface autophosphor- 
ylation activity coincided with a diminished capacity 
for endocytosis of ~25I-EGF with endocytosis returning 
to normal after the restoration of cell surface auto- 
phosphorylation activity. The inhibition of cell surface 
autophosphorylation activity and the activation of en- 
dosomal autophosphorylation activity coincident with 
downregulation suggest that EGF receptor traffic is 
governed by ligand-regulated  phosphorylation activity. 
T 
HE EGF receptor contains intrinsic tyrosine kinase ac- 
tivity which appears to be active after internalization 
into endosomes (12, 20).  EGF receptor tyrosine ki- 
nase activity has been postulated by Honegger et al.  (19) to 
control downregulation.  Substitution of the ATP binding Lys 
721 of the receptor for Ala and subsequent transfection  into 
receptor-deficient  NIH 3T3 cells resulted in the absence of 
downregulation  but the maintenance  of receptor-mediated 
endocytosis of EGE Hence, constitutive  receptor recycling 
was proposed by these authors (19). The role of the tyrosine 
kinase domain of the EGF receptor in regulating internaliza- 
tion and traffic of the receptor has also been suggested by the 
mutational analyses carried out by Lin et al. (30), Prywes et 
al. (35), and Livneh et al. (31). Furthermore, Glenney et al. 
(18) have demonstrated that microinjection of anti-phospho- 
tyrosine antibody into receptor-transfected  Chinese hamster 
ovary cells inhibited ligand-mediated  EGF receptor internal- 
ization. 
The companion paper (29) demonstrated that downregula- 
tion of the EGF receptor in vivo was evident at saturating 
doses of injected ligand  but not when receptor occupancy 
was ~<50%. Downregulation was speculated to be some con- 
sequence of the interaction  of a threshold concentration  of 
EGF and its receptor at the cell surface and/or in endosomes. 
Sorting of incoming receptors and ligands is regulated within 
the endosomal apparatus  (6, 21, 33, 40), and EGF receptor 
phosphorylation is ligand dependent.  We have consequently 
examined the degree of association of EGF with its receptor 
in endosomes as a function of the dose of EGF injected.  Fur- 
thermore,  the autophosphorylation activity of the receptor 
was evaluated in endosomes and at the cell surface as a con- 
sequence of the dose of injected EGE We have observed that 
the majority of internalized  EGF in endosomes is receptor 
bound and probably responsible for the enhanced autophos- 
phorylation activity of internalized EGF receptor kinase. We 
have also observed a transient  desensitization  of the auto- 
phosphorylation activity of the cell surface EGF receptor but 
only when  saturating  doses of ligand  were administered. 
This transient  desensitization  of autophosphorylation activ- 
ity coincided with a marked inhibition  in receptor-mediated 
endocytosis of EGF in vivo. 
Materials and Methods 
Materials. animals, EGF iodination, binding assays, SDS-PAGE, and sub- 
cellular fractionation protocols were as described in the companion pa- 
per (29). 
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Selective Precipitation 
Several  modifications of the  polyethylene  glycol  (PEG) I  precipitation 
method of Cuatrecasas (14) were necessary to evaluate  the proportion of 
EGF bound to receptor within isolated endosomes. Control experiments 
were carried out to assess the effects of solubilization by Triton X-100. 
Steady-state direct binding of I251-EGF to plasmalemma (PM) and Golgi 
apparatus-endosome (GE) fractions were carried out as described previ- 
ously with 50/tg protein of PM or GE fractions incubated in a final volume 
of 0.5 ml with 125I-EGF (75,000 dpm, 180 #Ci//zg sp act) for 14 h at 4°C 
with constant shaking (27).  Ligand binding was determined by filtration. 
Solubilization of cell fractions was assessed with increasing concentrations 
of Triton X-100 (at 0°C for 3 rain) followed by filtration on Whatman filters 
(9).  Receptor-ligand complexes were precipitated by the addition of 1 ml 
of 0.125%  3,-globulin  and 1 ml of 25% PEG 8000 for 30 min at 4°C as in 
the method of Cuatrecasas (14). 
Modifications included the addition of Con A (1 mg/ml) or a mixture of 
the lectins (Con A, wheat germ agglutinin, and Lens culinaris lectin;  1 
mg/ml each) based on the prior studies of Krupp et al. (25) and Yarden et 
al, (41). Tubes containing the receptor-ligand complexes were at 4°C and 
Con A or lectin mixtures were added (at 4°C for 30 rain) followed by the 
addition of PEG and 3,-globulin  as described above.  As documented in 
Results, the final protocol which was efficient in separating free ligand from 
receptor-bound ligand was 0.5 % Triton X-100, T-globulin, PEG, and the lec- 
tin mixture (concentrations as above) all added together with the cell frac- 
tion for 30 min at 4°C followed by filtration. 
Evaluation of Receptor-bound EGF by Quantitative 
Radioautography 
GE fractions were prepared 15 min after a portal vein injection of ~25I-EGF 
(10 #g/100 g body weight, 7.5  x  109 dpm, 259/zCi//tg sp act) and fixed 
in 2.5% glutaraldehyde in 100 mM sodium cacodylate, pH 7.4, at 4°C over- 
night. Aliquots containing 30/~g of fraction protein were filtered onto filters 
(MF type; Millipore Continental Water Systems, Bedford, MA) under N2 
(flow rate 3-5 psi) using a filtration apparatus as described previously (1). 
The filters were processed for electron microscope radioautography (22, 
23). Radioautographs exposed between 10 and 14 d were grid stained with 
lead citrate (36) and viewed in the electron microscope (301; Philips Elec- 
tronic Instruments) calibrated with a carbon line-grating replica (SPI Sup- 
plies, West Chester, PA). 
Endosomal components overlaid with silver grains were photographed 
at random along the fraction pellicle, and micrographs were enlarged to a 
final  magnification of 70,000x.  Endosomes of a diameter <200 nm were 
not included in the sampling since this was the lower size limit for distin- 
guishing grain density distributions over membrane and content (37).  The 
exclusion of this category of endosomal profiles represented 35 % of the total 
silver grains of  the radioautograph. A grain density distribution analysis was 
performed on endosomal profiles included in the sample (average diameter 
320 nm) exactly as outlined by Salpoter et al. (37). Briefly, distances of sin- 
gle or grouped clusters of silver grains, defined as emanating from a single 
emulsion crystal (23, 24) (n =  370), to the endosomal membrane were mea- 
sured with a  digitizer (MOP3;  Carl  Zeiss Instruments, Ltd.,  Montreal, 
Canada). These distances were allocated to discrete distance bins (64 nm) 
lying concentrically inside or outside endosomal profiles. Grain densities 
(number of grains/area of bin) for the distance bins were calculated and ex- 
pressed relative to that straddling the membrane. 
EGF Receptor Autophosphorylation Activity and 
SDS-PAGE 
EGF receptor autophosphorylation activity was evaluated  with PM (30-50 
/tg protein) or GE fractions (30-40 t~g protein) in the presence or absence 
of Triton X-100 (0.05% vol/vol) with or without EGF (0.8 ~M) as described 
previously (20). SDS-PAGE on 5-15% linear polyacrylamide gels was car- 
tied out as described earlier (20).  Alkali treatment of SDS gels was per- 
formed by the method of Cooper et al.  (13). 
Monoclonal Antibody to EGF Receptor 
A hybridoma, secreting anti-EGF receptor antibodies (IgG-151), was kindly 
1. Abbreviations used in this paper:  GE, Golgi apparatus and endosome; 
PEG, polyethylene glycol; PM, plasmalemma. 
provided by Dr. C. E. Chandler (Stanford University, Stanford, CA) and was 
subcloned (IgG-151, BH-6) by Drs. W. Dunn and A. L. Hubbard (The Johns 
Hopkins University, Baltimore, MD). Antibodies were isolated from cell 
culture supernatants (11) or from ascites fluid (34) and were purified by pro- 
tein A-Sepharose chromatography. Control experiments showed that IgG- 
151  was a competitive inhibitor of 125I-EGF binding as well as for EGF- 
stimulating receptor kinase activity in both PM and GE fractions from rat 
liver (data not shown). The antibody was not, however, useful for quantita- 
tive immunoblotting. 
lmmunoprecipitation of EGF Receptor 
EGF receptor was immunoprecipitated with monoclonal antibody IgG-151, 
BH-6 (11) as described by Gill et al. (17). At the end of the autophosphoryla- 
tion assay,  10 #l of 50 mM ATP in 20 mM Hepes, pH 7.4,  was added to 
stop the reaction. The membranes were then solubilized in RIPA buffer con- 
raining 50 mM Tris-HCI, pH 7.2, 0.15 N NaCl, 5 mM EDTA, 1% sodium 
deoxycholate, 0.1% SDS, and 100 kallikrein inhibitor units/ml aprotinin for 
30 min with constant shaking at 4°C.  Monoclonal antibody to the EGF 
receptor was added to a final concentration of 0.3 #M for 30 min at 4°C. 
50 ~l of a  10% (wt/vol) suspension of formaldehyde-fixed Staphylococcus 
aureus (Calbiochem-Behring Corp., La Joila, CA) was then added to the 
tubes and incubated for an additional 30 rain at 4°C. The entire mixture was 
layered onto a 0.75-ml cushion of I  M sucrose in 20 mM Hepes, pH 7.5, 
and centrifuged for 3 min. The pellet was washed twice with RIPA buffer 
and pelleted by centrifugation, once with 0.5 N NaCl in 20 mM Hepes, pH 
7.5, and once with double-distilled water. The pellet was then boiled for 2 
rain in sample preparation buffer, the bacteria were removed by centrifuga- 
tion, and supernatants were processed for SDS-PAGE. 
Phosphatase Preparation 
The liver cytosolic fraction which was used as a source of tyrosine phospha- 
tase activity was prepared in 0.25 M sucrose solution with protease inhibi- 
tors (1 mM benzamidine, 50 #M pepstatin, 1 mM PMSE and 1,000 kal- 
likrein inhibitor units/ml aprotinin). The homogenate was adjusted to 20% 
with 0.25 M sucrose with inhibitors and centrifuged at 1,000 g for 10 rain 
at 4°C. The supernatant was saved and centrifuged at 160,000 g for 35 min 
at 4°C. The resulting supernatant was saved and purified in a Sephadex G-50 
column preequilibrated with 40 ml 50 mM Tris base, pH 7.4,  containing 
protease inhibitors as described above. The effluent was divided into two 
separate aliquots and combined with either 50 mM Tris base, pH 7.4, con- 
tamining protease inhihitors or containing protease inhihitors plus the phos- 
phatase inhibitors (0.8 mM ZnSO4, 80/~M sodium vanadate,  160 mM so- 
dium molybdate, 56 mM sodium fluoride, 160 mM/3-glycerophosphate) in 
a 3:1 ratio (vol/vol). 
EGF Receptor Dephosphorylation and 
Rephosphorylation 
Samples were phosphoryinted and terminated with 10/~1 of 50 mM ATP in 
20 mM Hepes, pH 7.5. Dephosphorylation was initiated with the addition 
of 200/tl of freshly prepared cytosolic phosphatase at 22°C for 30 rain, the 
reaction was stopped by adding equal volumes of 2x  concentrated SDS- 
PAGE  sample  preparation  buffer,  and  the  samples  were  boiled.  The 
rephosphorylation assay was carried out as follows. Aliquots of PM were 
incubated with equal volumes of cytosolic phospha~ at 22°C for 30 min, 
and samples were dephosphorylated as described above. At the end of de- 
phosphorylation, the reactions were terminated by the addition of phospha- 
tase inhibitors at 4°C. Samples were centrifuged at 100,000 g  for 30 rain 
at 4°C. The supernatant was removed, the pellet was reSUSlmaded in 75/~i 
of 0.25 M STM (0.25 M sucrose, 5 mM Tris, pH 7.4, 1 mM MgCh) with 
75 ~1 of  the phosphorylation assay buffer, and EGF aumpbosphorylalion ac- 
tivity was evaluated with [3'-32P]ATP with or without EGF as described 
above. 
Results 
Conditions for Estimation of  Ligand-Receptor 
Complexes in PM and GE Fractions 
Control experiments were carried out to evaluate the reten- 
tion of ligand-receptor complexes in PM after solubilization 
with Triton X-100.  Direct binding  of m25I-EGF to PM  was 
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ing ligand-receptor complexes for EGF in PM 
(A) and GE fractions  (B) and the demonstra- 
tion of ligand-receptor association in isolated 
GE fractions (C). (A and B) Direct binding of 
~25I-EGF under  steady-state conditions  to in- 
tact PM and GE fractions was carried  out as 
described  in  the  companion  paper (29) and 
normalized  to  100%. Membranes  were  then 
evaluated for solubilization by increasing con- 
centrations  of Triton X-100 alone  (o) as as- 
sessed by filtration. For each concentration of 
Triton X-100, the retention of ligand-receptor 
complexes was assessed by PEG precipitation 
with 't-globulin followed by filtration (A). This 
was compared with the retention of complexes 
after a 3-min solubilization in Triton X-100 fol- 
lowed by the addition  of lectin  mixtures  fol- 
lowed by PEG with  't-globulin  together  (o). 
This is also compared with conditions where 
Triton  X-100, lectins,  PEG,  and  -t-globulin 
were  all added together  (I).  Only  under  the 
latter  conditions  were  ligand-receptor  com- 
plexes maintained in solubilized (0.5% Triton 
X-100) PM or GE fractions.  (C)  Degree  of 
receptor-ligand  association in GE fractions as 
a function of the dose of EGF injected. At 15 
min after the injection of 0.1,  1, and  10 #g of 
~2SI-EGE GE fractions  were isolated and the 
proportion  of free and receptor-bound  ligand 
estimated by the addition of  a mixture of  Triton 
X-100, lectins, PEG,  and 't-globulin  (mean of 
three experiments  +  SD and each determina- 
tion was carried  out in triplicate). 
carried out at steady state. As shown in Fig. 1 A, the addition 
of Triton X-100 alone to PM with receptor-bound ~zSI-EGF 
led to the loss of 50%  of radiolabel to the soluble fraction 
at a concentration of 0.18%  Triton X-100.  Solubilization of 
PM occurred with  1% Triton X-100 at which only 18%  of 
radiolabel was retained by filtration. Subsequent attempts to 
precipitate solubilized ligand-receptor complexes with PEG 
and 3,-globulin alone were unsuccessful. Indeed, the addition 
of PEG and 3,-globulin 3 min after Triton X-100 solubiliza- 
tion appeared to promote ligand dissociation from receptor 
since 50% of radiolabel was not retained by filtration when 
the concentration of Triton X-100 was only 0.08 % and only 
14 % of radiolabel was retained at 1% Triton X-100. The addi- 
tion  of a  cocktail  of lectins  along  with  PEG  3  min  after 
solubilization  led  to more complete retention of receptor- 
bound EGF, with 57 % of the radiolabel retained at concen- 
trations as high as 1% Triton X-100.  Only with a protocol in 
which Triton X-100, PEG, and the lectin cocktail were added 
together could solubilization be effected with complete reten- 
tion of receptor-bound ligand (Fig. 1 A). The use of the same 
conditions  to  evaluate  the  retention  of EGF  bound  to  its 
receptor in GE fractions showed a similar response to Triton 
X-100 alone and to the addition of PEG 3 min after Triton 
X-100 (Fig.  1 B). However, in contrast to the EGF receptor 
of PM, the addition of PEG plus lectins 3 min after solubili- 
zation  with  Triton  X-100  was  as  efficient  in  maintaining 
ligand-receptor association as the addition of the PEG plus 
lectin cocktail plus Triton X-100.  The differences between 
the data of Fig.  1, A and B, related only to conditions where 
the  lectins  were added  3  min after Triton X-100 and may 
reflect differences in the aggregation state of glycoconjugates 
(lectin-binding sites) found between PM and GE fractions. 
The degree of ligand-receptor association in isolated GE 
fractions was assessed as a function of the dose of EGF in- 
jected into rats.  Under conditions that solubilized the frac- 
tions with minimal EGF dissociation -  i.e., with the cock- 
tail of Triton X-100,  lectins, ~/-globulin, and PEG -  ,~,57% 
of ~25I-EGF in  endosomes was receptor bound at doses of 
EGF injected of 0.1  and 1 #g EGF/100 g body weight. The 
value increased to 77%  receptor bound at  10 #g EGF in- 
jected (Fig.  1 C). 
The degree of ligand-receptor association in the GE frac- 
tion was evaluated further by the technique of quantitative 
electron microscope radioautography. 15 min after the injec- 
tion of 10 #g ~25I-EGF, GE fractions were isolated and pro- 
cessed for radioautography. Silver grains overlaid liver en- 
dosomes  with  their  characteristic  intralumiual  content  of 
lipoprotein-like particles  (Fig.  2).  Qualitatively,  the  silver 
grains seemed to be at the periphery of endosomes. Evalua- 
tion of the distribution of grain densities within and outside 
of endosomes (Fig.  3)  showed a  peak over the endosomal 
membrane. Grain densities decreased markedly as a function 
of distance outside the endosomal profile and also decreased 
(although less so) as a  function of distance within the en- 
dosome. 
As proposed by Salpeter et al.  (37), consideration of the 
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of GE  fractions  containing  a25I-EGE At  15 
min after the portal vein injection of '25I-EGF 
(10 ttg/100 g body weight), the GE fractions 
were prepared  and harvested.  Aliquots were 
fixed and processed  for electron microscope 
radioautography as detailed in Materials and 
Methods.  Silver grains  emanating from '2sI- 
EGF can be seen over lipoprotein-filled (//7)  en- 
dosomes. In separate experiments, the majority 
(90%) of radioactivity contained within endo- 
somes was judged to be intact by the criteria of 
qUA precipitation and by acid elution followed 
by rebinding to human placental membranes. 
Exposure was for 10 d. Bar, 0.1 tLm. 
half-distance of 'zSI,EGF  (80 um in our hands [5]) and the 
diameter of the vesicular profiles under analysis allows one 
to  calculate  the  expected  distribution  of grain  densities 
whether the source of radiolabel was free in the lumen or ex- 
clusively membrane bound. Such a calculation showed that 
the distribution expected for a membrane-bound source (Fig. 
3, dashed line) closely approximated the observed distribu- 
tion of grain densities  (histogram).  The limitation of this 
analysis was such that only endosomal profiles of diameter 
>200 nm could be included in the study. At diameters less 
than this, the distribution of silver grains expected for a uni- 
form intraluminal source of radioactivity became very simi- 
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Figure 3.  Localization of t25I- 
EGF to the endosomal mem- 
brane. Grain densities (histo- 
grams) within (<0) or outside 
(>0) the endosome were de- 
termined as described in Ma- 
terials and Methods and com- 
pared with the distribution of 
grain  densities  expected  for 
a  membrane  source  (dashed 
line) or content source of ra- 
dioactivity (solid line) as cal- 
culated according to Salpeter 
et al. (37). 
lar to that for a membrane source (37). These smaller vesi- 
cles,  however, accounted for only 35%  of the total silver 
grains; therefore, the majority of '~5I-EGF in the endosome 
preparation was subjected to the analysis of Fig. 3. Compari- 
son of the empirically determined grain densities with the 
calculated  distribution  of  grain  densities  indicated  that 
>99% of  the silver grains analyzed were from a radiolabeled 
source at the periphery of  endosomes of  the GE fraction. The 
radioautographic technique was impractical for lower doses 
of ~25I-EGF injected (0.1 and 1/~g) since the number of sil- 
ver grains were too few for statistical analysis. 
Autophosphorylation Activity and Receptor Recycling 
The intraendosomal association of EGF with its receptor at 
the bounding membrane of endosomes prompted the study 
of changes in autophosphorylation activity during internal- 
ization and recycling. Autophosphorylation studies were car- 
ried out on intact and solubilized fractions in the presence 
or absence of in vitro-saturating concentrations of EGF to 
evaluate the endogenous autophosphorylation activity as a 
function of the maximal stimulated activity. (Electron mi- 
croscopy showed no difference in the morphology of GE 
fractions after autophosphorylation assays carried out in the 
absence of detergent as compared with freshly prepared GE 
fractions.) As our past study has shown (20), most of the au- 
tophosphorylation of the EGF receptor under these condi- 
tions was on tyrosine residues. Therefore, evaluation of auto- 
phosphorylation was carried out after alkali treatment of gels 
03). This simplified the phosphopeptide pattern enabling the 
ready observation of  the band at 170 kD corresponding to the 
EGF receptor (Fig. 4). Thi  s protein was identified further as 
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by EGF receptor kinase of PM isolated at 15 
and 120 min after injection of 1-10/~g EGF/ 
100 g body weight. Control animals (0 rain) re- 
ceived no injection. Autophosphorylation  was 
carried out as described in Materials and Meth- 
ods,  and  PM  was  subjected to  SDS-PAGE, 
alkali treatment, and radioautography (expo- 
sure for 7.5 h). The band indicated as EGF-R 
corresponds to the EGF receptor as determined 
by immunoprecipitation with the monoclonal 
antibody IgG-151, BH-6 (Fig. 6).  Molecular 
weight markers are indicated on the left. Equal 
amounts of protein (6 pg) were applied to each 
lane. 
the EGF receptor by immunoprecipitation with the monoclo- 
hal antibody IgG-151, BH-6 (see below). Visual analysis of 
the intensity of labeling of the EGF receptor in PM at 15 and 
120 min after the in vivo injection of 1, 5, and 10 ~g EGF/ 
100 g body weight showed a decrease at 15 min, the magni- 
tude of which was larger as the amount of EGF injected was 
increased.  By 120 min, 32p-labeled receptor was more in- 
tensely labeled than at 15 min for each dose of EGF injected 
(Fig. 4). 
No lag preceded the loss of autopbosphorylation activity 
from the PM or its accumulation into GE fractions (Fig. 5). 
Rates of loss of autophosphorylation activity from the PM 
were rapid and increased progressively from 0.15 min  -~ for 
0.5 ~g EGF injected to 0.9 min  -~ at 10 ~g EGF injected un- 
der the  in  vitro assay conditions of maximal stimulation 
(with EGF and Triton X-100 in vitro). The rate of entry of 
the activity into GE fractions was correspondingly rapid 
(Fig.  5). 
Augmentation of  autophosphorylation  activity  by in  vitro 
EGF was observed  for PM-located receptor.  However, at 
high doses of EGF injected (5 and 10 ~g), autopbosphoryla- 
tion activity was nearly completely inhibited on the PM at 
15 rain after injection in confirmation of our past study at 
even higher doses of EGF injected (20).  Also, as reported 
previously by us (20) and confirmed here, high doses of in- 
jected EGF (i.e., 10/Lg) appeared to activate maximally au- 
tophosphorylation activity in the GE fraction whether or not 
EGF was added in vitro. At lower doses injected (0.1-1 ~g), 
autophosphorylation activity was augmented by in vitro EGF 
added to GE fractions providing that Triton X-100 was pres- 
ent in the incubation mixture. 
Immunoprecipitation  studies  (Fig.  6)  confirmed  the 
marked changes in autophosphorylation activity observed on 
the PM. To evaluate the contribution of newly synthesized 
protein to the autophosphorylation activity observed at 120 
min, experiments were also carried out on fractions isolated 
from cycloheximide-injected rats. Quantitation (Fig. 7) con- 
firmed the marked inhibition of autophosphorylation at 15 
rain after the injection of high doses of EGF (5 and 10 ~g) 
and the reappearance of autophosphorylation activity at 120 
min, which was least at the highest dose of injected EGF 
(10 ~g). 
EGF  Receptor Dephosphorylation  and 
Rephosphorylation 
Autophosphorylation activity at 15 min after the injection of 
saturating doses of EGF (5 and 10/~g) was almost zero in 
PM fractions (Figs.  5  and 7) whereas  '~25-40%  of EGF 
receptors, as evaluated by direct binding or immunoblotting, 
remained on the cell surface (see Figs. 1, 3, and 5 of the com- 
panion paper [29]).  This apparent desensitization of auto- 
phosphorylation activity was evaluated further. PM fractions 
were isolated at 15 rain after the injection of  a saturating dose 
of EGE We then attempted to dephosphorylate then rephos- 
phorylate the membranes in the presence and absence of 
EGF in vitro. 
As shown in Fig. 8 A, receptor autophosphorylation in PM 
isolated from control (uninjected) rats (lanes 1 and 3) or 15 
min  (lanes  2  and  4)  after  EGF  injection  showed  EGF- 
dependent autophosphorylation activity only for the PM iso- 
lated from uninjected rats (lane 3).  Fig. 8 B demonstrated 
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Figure.5. Dose dependency of changes in autophosphorylation ac- 
tivity in PM and GE fractions.  Autophosphorylation activity per 
unit cell fraction protein is shown for conditions of incubations car- 
ried out in the presence of 0.05% Triton X-100 with (o) or without 
(o) EGF in vitro. Similar findings were observed in the absence of 
Triton X-100 except for latency in endosomes (20). 
with control experiments where 0.1,  1, and  10 #g '25I-EGF 
were injecle.A into control (uninjected) rats, and the GE frac- 
tion  was isolated  15  min later (open bars).  An  additional 
control was designed to account for any changes in specific 
radioactivity of the  125I-EGF due to the possibility of dilu- 
tion in the circulation of previously injected unlabeled EGE 
Hence, rats were injected with either a mixture of 0.1 #g un- 
labeled  EGF  plus  0.1  #g  ~25I-EGF; 1  #g  unlabeled  EGF 
plus 1 #g t2~I-EGF; or 5 #g unlabeled EGF plus 10/~g ~z~I- 
EGE GE fractions were isolated 15 min later (slashed bars). 
Extensive internalization of t2~I-EGF was observed for both 
sets of controls (Fig.  9). 
that  the  EGF  receptor could  be dephosphorylated by the 
phosphatase activity of liver cytosol (lanes 5,  6,  9, and 10). 
This  dephosphorylation  was  inhibited  by  the  addition  of 
phosphatase inhibitors (lanes 7, 8,//, and 12). However, the 
phosphatase inhibitors appeared to be only partially effective 
as the level of phosphorylation appeared slightly lower than 
controls (i.e.,  lanes 1-4).  Further experimentation showed 
that  the  dephosphorylated receptor could then be rephos- 
phorylated but only back to near original (control; lanes 1-4) 
levels (Fig.  8  C,  lanes 13-20). 
Desensitization of  Autophosphorylation Coincides 
with Diminished Internalization 
We evaluated ligand internalization at 15 min after the injec- 
tion of saturating doses of EGF -  i.e., when autophosphory- 
lation activity was minimal.  The experimental design con- 
sisted of injecting 0.1, 1, and 10/xg 12~I-EGF at 10 min after 
the previous injection of 0.1,  1, and 5/~g of unlabeled EGE 
Rats were then killed 15 min later and the GE fraction was 
isolated.  The  results  (Fig.  9,  solid  bars)  showed  a  high 
proportion of ligand internalized at the 0.1- and  1-/xg doses 
but not at the 5-/xg dose. These observations were compared 
Figure 6. Immunoprecipitation of EGF receptor kinase of PM after 
in vitro autophosphorylation.  At 0, 15, and 120 min after EGF in- 
jection,  PM  was isolated  from untreated  (A) or cycloheximide- 
treated  (B) rats,  and autophosphorylation  was carried  out.  EGF 
receptor kinase was immunoprecipitated with monoclonal antibody 
IgG-151, BH-6. The immunoprecipitate was electrophoresed,  and 
alkali-treated gels were exposed to x-ray film for 1.5 d. Lanes 1 in 
A and B refer to immunoprecipitations carried out with rabbit anti- 
mouse IgG instead of monoclonal antibody IgG-151, BH-6. Each 
lane represents an immunoprecipitation  carried  out on 6/~g PM 
protein. 
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Figure 7. In vivo dose response of autophosphory- 
lation  activity  in PM  without EGF  injection  (0 
min) and  15 and  120 min after the injection  with 
0.1  (o),  1 (a),  and  10 #g EGF (ll).  After auto- 
phosphorylation (with  EGF and Triton  X-100 in 
vitro), EGF receptor was immunoprecipitated  and 
subjected to SDS-PAGE and radioautography,  and 
the incorporated radioactivity quantified  by den- 
sitometry. The number of experiments  is indicated 
in parentheses. 
A further ligand internalization study was carried out at 60 
min after the injection of EGF -  i.e., when autophosphory- 
lation activity was restored. At this time interval, the recep- 
tor content of the PM fraction had returned  to near initial 
values  for the 0.1-  and  1-#g doses of injected EGF but re- 
mained downregulated at the 10-#g dose (29). Tracer doses 
of '25I-EGF were  injected  at 60 min after the  injection  of 
0.1,  1, and  10 #g EGF/100 g body weight.  The kinetics and 
extent  of  '2q-EGF  accumulation  in  the  GE  fraction  was 
evaluated  (Fig.  10)  and found to be near identical. 
Figure 8.  EGF receptor protein autophosphorylation, dephosphorylation, and rephosphorylation in PM. The radioautograph  shows auto- 
phosphorylation activity with control PM fractions (without EGF injection;  lanes 1, 3, 5,  7, 9, 11, 13, 15, 17, and 19) and in PM fractions 
isolated at 15 min after the injection of 10 #g/100 g body weight EGF (lanes 2, 4, 6, 8, 10, 12, 14, 16, 18, and 20). (A) Autophosphorylation 
of the EGF receptor.  PM was isolated  and incubated  in the standard  autophosphorylation assay as described in Materials  and Methods 
in the absence (lanes 1 and 2) and the presence (lanes 3 and 4) of in vitro EGE (B) Dephosphorylation by cytosolic phosphatase.  Dephos- 
phorylation was carried out after prior autophosphorylation without EGF in vitro (lanes  5-8)  and with EGF in vitro (lanes  9--12), and 
the samples were electrophoresed as described in Materials and Methods. Controls were carried out in which the dephosphorylation reaction 
was carried out in the presence of phosphatase inhibitors  (lanes  7, & 11, and I2).  (C) Rephosphorylation of the EGF receptor.  Samples 
of  dephosphorylated PM-i.e., B was rephosphorylated in the absence (lanes 13-16) or presence (lanes 17-20) of in vitro EGE SDS-PAGE, 
alkali treatment,  and radioautography (exposure  for 16 h) was carried out as described in Materials  and Methods.  The band indicated  as 
EGF-R corresponds to the EGF receptor as determined by immunoprecipitation  with the monoclonal antibody IgG-151, BH-6 (Fig.  6). 
Each lane represents  4.8 #g PM protein. 
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Figure 9. Ligand-induced desensitization of internalization. (Solid 
bars) The injection of 0.1, 1, and5 #g EGF/100 g body weight via 
the hepatic portal vein was carried out 10 min before the subsequent 
portal vein injection of 0.1,  1, and  10 #g of J25I-EGF/100 g body 
weight (192/~Ci/#g sp act).  15 min later, animals were killed, GE 
fractions were prepared from liver homogenates, and radioactive 
content was determined. Two control experiments were done. In the 
first (open bars), 0.1, 1, and  10 #g z25I-EGF  was injected and GE 
fractions isolated  15 min later. In the second control experiment 
(slashed bars), the specific activity of the radiolabel was reduced 
by first mixing (a) 0.1 ttg of unlabeled EGF with 0.1 #g t25I-EGF 
(left slashed bar); (b) 1 #g of unlabeled EGF with 1 #g ~25I-EGF 
(center slashed bar); or (c) 10 ttg  12SI-EGF with 5/zg unlabeled 
EGF (right slashed bar). GE fractions were isolated 15 rain after 
injection,  and  radioactive content  was determined.  Data are ex- 
pressed as percent of maximal internalization for each dose of EGF 
injected. Maximal internalization (open bars) at the 0.1-#g dose of 
~2SI-EGF was 1.5  x  106 dpm/mg cell fraction protein; at the l-#g 
dose of ~25I-EGF, 3.6  x  107 dpm/mg cell fraction protein; and, at 
the 10-#g dose of '25I-EGE 9.5  ×  107 dpm/mg cell fraction protein. 
Discussion 
The dose dependency of EGF receptor downregulation re- 
ported in the companion paper (29) prompted an analysis of 
ligand-receptor association in the endosome. Receptor-bound 
EGF might influence both receptor traffic (7, 40) as well as 
transmembrane signaling therein (12, 20). We therefore esti- 
mated the degree of EGF bound to receptor in the endosome 
and compared the autophosphorylation activity of the EGF 
receptor kinase in GE with PM fractions. 
Ligand-Receptor Association in Endosomes 
The association of EGF with its receptor was labile to low 
doses of Triton X-100 (Fig.  1). Past studies of Carpenter (9), 
Krupp et al. (25), as well as Yarden and Schlessinger (41), 
have indicated difficulty in optimizing conditions for binding 
EGF to its receptor in solubilized preparations. We have used 
a modification of their protocols involving the addition of a 
cocktail of lectins,  PEG, and ),-globulin along with Triton 
X-100 to rat liver PM or GE fractions. Control experiments 
in which the recovery of ligand-receptor complexes was as- 
sessed after direct binding to test membranes validated our 
protocol. At three doses of EGF injected (0.1,  1, and l0 #g 
EGF), receptor occupancy was evaluated by the above pro- 
tocol. At peak times of internalization in the endosome (i.e., 
15  rain),  the  majority  of internalized  EGF  was  receptor 
bound for all doses of injected EGE Greatest receptor oc- 
cupancy (77 %) was observed at the saturation dose as might 
be expected from the law of mass action. 
The independent protocol of quantitative radioautography 
indicated that all of the EGF was membrane bound in iso- 
lated GE fractions at the 10-#g dose of EGF injected. This 
latter technique extended the biochemical determinations of 
Fig.  1;  it demonstrated that the ligand-receptor complexes 
were associated with the bounding membrane of the liver en- 
dosome  and  not  to  any  intraluminal  vesicles.  This  is  a 
noteworthy finding as it positions the receptor kinase to a site 
available for interaction with the cytosol. 
The endosomal apparatus is acidic,  although the acidity 
seems greater for late as opposed to early endosomes (6, 16). 
Nevertheless, even at pH 6, little EGF has been demonstrated 
to bind to receptor in vitro during direct binding studies (15, 
27),  As discussed elsewhere (4), the small volume of endo- 
somes (10  -t7 liters)  and the high concentration of intraen- 
dosomal ligand could act to promote ligand-receptor associ- 
ation and  counteract the  low pH-induced  increase  in  Kd. 
The present observations on the intraendosomal association 
of EGF with its receptor are consistent with past observa- 
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Figure 10.  Internalization  of 
*25I-EGF in GE fractions.  60 
min after the portal vein injec- 
tion of 0.1, 1, and 10 #g unla- 
beled EGF/100 g body weight, 
tracer  amounts  of  125I-EGF 
(0.08 #g,  180 #Ci/#g sp act) 
were then injected via the por- 
tal vein. GE fractions were iso- 
lated at various times after the 
injection of t25I-EGF as indi- 
cated.  Ligand  internalization 
was evaluated by counting the 
endosomal  aliquots  in tripli- 
cates  and  expressed  as pico- 
moles of '25I-EGF  internalized 
per  milligram  cell  fraction 
protein.  The  abscissa  repre- 
sents time after the  injection 
of '25I-EGE 
The Journal of Cell Biology, Volume 109,  1989  2758 tions made by us and others indicating that internalized EGF 
is receptor bound within the endosomal apparatus.  Thus, 
McKanna et al. (32) showed with ferritin-EGF in A431 cells 
a close association of ferritin with the bounding membrane 
of intracellular vesicles that we would now call endosomes 
but not with intraluminal vesicles of the temporally later 
multivesicular bodies. Lai et al. (28) using quantitative ra- 
dioautography observed ~25I-EGF at the periphery of endo- 
somes in placental syncytiotrophoblasts although radiolabel 
was found within the lumina of multivesicular bodies.  By 
protein A-gold immunocytochemistry  of Lowicryl-embedded 
A431 cells,  Carpentier et al.  (10) have also observed the 
majority of EGF associated with the intraluminal periphery 
of endosomes. Finally, Sorkin et al.  (39)  have concluded 
from studies using mild extraction protocols with the deter- 
gent Brij-58 that the majority of EGF internalized into en- 
dosomes of A431 cells is receptor bound. Taken together, 
therefore, the results from A431 cells, placenta, and liver 
parenchyma using a variety of biochemical and morphologi- 
cal  methods all agree  that the majority of EGF remains 
bound to its receptor in the bounding membrane of the endo- 
some. This is relevant to a consideration of models for ex- 
plaining EGF receptor traffic in liver and the relationship be- 
tween internalization and transmembrane signaling of the 
EGF receptor kinase. 
EGF Receptor  Autophosphorylation Activity 
An important consequence of the interaction of EGF with its 
receptor is the enhancement of  receptor autophosphorylation 
activity.  The  relatively  simple  pattern  of in  vitro  phos- 
phorylated polypeptides of GE and PM fractions after incu- 
bation with [-y-32p]ATP at 4°C and the ready identification 
of the 170,000-Mr EGF receptor (20) which was confirmed 
further by immunoprecipitation studies with monoclonal an- 
tibody enabled the screening of EGF receptor autophosphor- 
ylation at several time points after the injection of various 
doses of EGE For the GE fraction, from control (uninjected) 
rats, maximal autophosphorylation activity was observed in 
the presence of in vitro EGF provided the detergent Triton 
X-100 was present (20). (Similar results were observed in the 
absence of detergent except for latency in endosomes [20]). 
In the absence of in vitro EGE a dose-dependent increase 
in autophosphorylation activity was observed. Thus, at max- 
imal doses of injected EGF- i.e., 10 #g in the present study 
(Fig. 5) or 60 #g/100 g body weight in our past study (20)- 
little effect of in vitro EGF was observed on autophosphory- 
lation activity. This increased basal (without EGF, in vitro) 
autophosphorylation activity was most probably related to 
the increased proportion of receptor-bound EGF in the GE 
fraction at 15 min after the injection of 10 #g EGF (Fig. 1). 
Therefore, ligand content, receptor content, the propor- 
tion of EGF bound to its receptor, and basal autophosphory- 
lation activity are maximal in endosomes under conditions 
promoting receptor downregulation. These observations are 
all consistent with the hypothesis of Honegger et al. (19) that 
tyrosine kinase activity of the EGF receptor may control 
downregulation. In site-specific mutants of the EGF receptor 
where the ATP binding Lys 721  was  substituted for Ala, 
downregulation was abolished although internalization was 
maintained. Although only a correlation between downregu- 
lation and elevated endosomal autophosphorylation activity 
has been demonstrated, it seems reasonable to speculate that 
some function of receptor kinase activity in the endosome 
such as interactions with a  novel substrate may be linked 
causally to downregulation. 
Additional studies are required to clarify the mechanism 
of downregulation and EGF receptor recycling.  Thr 654 
phosphorylation of the EGF receptor by protein kinase C 
results  in  receptor  internalization  and  recycling  but  not 
downregulation  (2).  Recently,  the  E3  gene  product  of 
adenovirus has been shown to downregulate EGF receptor 
by a mechanism speculated to involve the formation of het- 
erooligomers between the E3  gene product and the EGF 
receptor (8). As viral gene products may mimic normal cel- 
lular counterparts, then the dose dependence of downregula- 
tion we  have observed  may also reflect ligand-dependent 
receptor oligomerization with a yet to be described cellular 
counterpart to the E3 gene product. 
PM fractions were also studied for autophosphorylation 
activity of the EGF receptor kinase. In confirmation of our 
previously published study (20)  which used much higher 
doses of injected EGF (60/xg/100 g body weight), we ob- 
served here a near complete inhibition of autophosphoryla- 
tion activity in the PM fraction at 15 min after injection. The 
dose-response studies (Fig.  5)  showed, however,  that this 
phenomenon was restricted to saturation doses (5 and 10/zg) 
of injected EGF. At lower doses, the diminution in autophos- 
phorylation activity at  15  min approximated the drop  in 
receptor content as assessed by direct binding (cf. Figs. 1 and 
5 of the companion paper [29]). 
The phenomenon was studied in greater detail. It was not 
related to rapidly turning over protein as dose-dependent in- 
hibition of autophosphorylation activity at 15 min in PM was 
also  observed  in  cycloheximide-treated  rats.  When  this 
phenomenon was originally observed we suggested (20) that 
the inability to autophosphorylate in vitro may reflect a high 
level of autophosphorylation in vivo which would have oc- 
cluded Tyr residues for further autophosphorylation in vitro. 
This  was  tested directly and  found to  be  incorrect.  The 
studies of Fig. 8 demonstrated that the EGF receptor in PM 
fractions isolated from control  (uninjected) rats could be 
autophosphorylated in  vitro,  dephosphorylated,  and  then 
rephosphorylated. In the case of PM isolated at 15 min after 
the injection of a saturating dose of EGE dephosphorylation 
did not result in the exposure of more available sites.  De- 
sensitization of the/$-adrenergic receptor is regulated by a 
~-adrenergic receptor kinase that phosphorylates preferen- 
tially the ligand-occupied receptor as well as by phosphory- 
lation from cAMP-dependent protein kinase C (3, 38). This 
model does not seem to apply, however, to the EGF receptor. 
Rather,  desensitization may  in  this  case  involve (ligand) 
dose-dependent formation of a complex of receptor with a 
yet to be described desensitizing molecule within PM. 
During the course of these studies, Kuppuswamy and Pike 
(26) demonstrated that 1 h after the incubation of 160 nM 
EGF to A431 cells the cells were densensitized for ligand- 
mediated internalization. We evaluated in liver parenchyma 
the internalization of ligand at the time of maximal desensiti- 
zation of autophosphorylation. This study (Fig. 9) confirmed 
and extended the observation of Kuppuswamy and Pike (26). 
However, we found that the downregulated state per se (i.e., 
at 60 min) did not affect the ability to internalize low doses 
of EGF (Fig. 10). We therefore propose that desensitization 
of ligand internalization may be linked to the reduced state 
Lai et al. EGF Receptor Traffic and Autophosphorylation  2759 of autophosphorylation activity in PM-located receptors but 
not simply to the downregulated state. The function of this 
transiently desensitized  state may be to limit the extent of 
downregulation and would explain why, even during condi- 
tions of vastly excessive EGF (20), receptor loss from the 
PM is limited to 60-75 % of the initial surface receptor con- 
tent. Taken together with the recent demonstration of Glen- 
ney et al. (18) that ligand-mediated receptor internalization 
is blocked after the microinjection of anti-phosphotyrosine 
antibodies  these  studies  suggest  a link between  the phos- 
phorylated state of the EGF receptor and internalization. 
In conclusion, our studies indicate that the EGF receptor 
content and autophosphorylation activities of the cell surface 
and internalized endosomaUy located receptor are regulated 
in a ligand-dependent fashion. The coincident inhibition of 
surface autophosphorylation activity and internalization as 
well as the enhancement of endosomal autophosphorylation 
activity coincident  with downregulation suggests that EGF 
receptor traffic is regulated by ligand-mediated EGF receptor 
phosphorylation activity. 
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